Pliant Therapeutics, Inc.
PLRX
$1.15
$0.021.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 158.10M | 170.89M | 190.94M | 241.80M | 262.87M |
| Total Receivables | 873.00K | 914.00K | 823.00K | 908.00K | 1.54M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.58M | 1.31M | 2.79M | 1.76M | 1.28M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.59M | 1.81M | 1.90M | 1.13M | 1.76M |
| Total Current Assets | 163.14M | 174.93M | 196.45M | 245.59M | 267.44M |
|
|
|||||
| Total Current Assets | 163.14M | 174.93M | 196.45M | 245.59M | 267.44M |
| Net Property, Plant & Equipment | 24.70M | 25.80M | 26.91M | 29.14M | 30.51M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.04M | 1.87M | 1.87M | 1.87M | 1.87M |
| Total Assets | 189.88M | 202.60M | 225.23M | 276.60M | 299.82M |
|
|
|||||
| Total Accounts Payable | 1.53M | 362.00K | 480.00K | 485.00K | 1.38M |
| Total Accrued Expenses | 12.68M | 8.28M | 14.44M | 15.95M | 17.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.27M | 1.71M | 1.45M | 1.19M | 1.23M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 16.48M | 10.36M | 16.37M | 17.62M | 20.59M |
|
|
|||||
| Total Current Liabilities | 16.48M | 10.36M | 16.37M | 17.62M | 20.59M |
| Long-Term Debt | -- | -- | -- | 30.44M | 30.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 26.47M | 27.07M | 27.66M | 28.23M | 28.79M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 42.96M | 37.43M | 44.02M | 76.29M | 79.74M |
|
|
|||||
| Common Stock & APIC | 1.05B | 1.04B | 1.04B | 1.04B | 1.03B |
| Retained Earnings | -901.81M | -879.44M | -859.40M | -835.82M | -809.52M |
| Treasury Stock & Other | -397.00K | -341.00K | -15.00K | 34.00K | -1.00K |
| Total Common Equity | 146.93M | 165.17M | 181.21M | 200.31M | 220.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 146.93M | 165.17M | 181.21M | 200.31M | 220.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 146.93M | 165.17M | 181.21M | 200.31M | 220.08M |
|
|
|||||